BioCentury | Apr 15, 2013
Company News

SyStemix, Novartis deal

...bid follows Novartis ' October bid of $17, which was rejected by STMX's independent directors. SyStemix Inc....
BioCentury | Mar 23, 2009
Finance

Ebb & Flow

...University and has helped form three stem cell companies: Cellerant Therapeutics , StemCells (NASDAQ:STEM) and Systemix...
BioCentury | Dec 4, 2006
Strategy

PER.C6 perseverance

...thinking beyond that," Valerio said. "In those days the leading gene therapy companies were Somatix, SyStemix...
BioCentury | Jun 2, 2003
Finance

Ebb & Flow

...period, 384 stocks have advanced. The BioCentury 100 has risen 39% since March 7. Rebirth Systemix...
...stem cell space, had a resurrection of sorts last week. Cellerant, which is based around Systemix...
...announced it exclusively licensed the IP rights from Stanford and Novartis (SWX:NOVN; NVS), which acquired Systemix...
BioCentury | May 29, 2003
Financial News

Cellerant raises $10 million

...was formed around the same IP that once was a part of another Weissman company, SyStemix...
BioCentury | Sep 4, 2001
Finance

Ebb & Flow

...of fetal tissue in research has recently been the subject of active political debate." - SyStemix's...
...the currently breathless media hoo hah, the controversy over stem cells is old hat. Recall SyStemix...
...marrow transplantation. And, like many of the companies that sold IPOs in the early 90s, SyStemix...
BioCentury | Jan 2, 2001
Company News

Axys management update

...Autoimmune/Inflammation Hired: Daniel Makover as VP of business development, formerly director of business development for SyStemix Inc. WIR...
BioCentury | Jul 17, 2000
Company News

Valentis management update

...as VP of medical and regulatory affairs, formerly executive director of clinical R&D at the Systemix/GTI...
BioCentury | Feb 7, 2000
Company News

CytoTherapeutics management update

...StemCells Inc. subsidiary Hired: Iris Brest as general counsel, formerly VP and general counsel for SyStemix Inc. WIR...
BioCentury | Jan 17, 2000
Company News

Targeted Genetics, Novartis deal

...Novartis subsidiaries Genetic Therapy Inc. (Gaithersburg, Md.) and SyStemix Inc. (Palo Alto, Calif.) received a non-exclusive, worldwide...
Items per page:
1 - 10 of 53
BioCentury | Apr 15, 2013
Company News

SyStemix, Novartis deal

...bid follows Novartis ' October bid of $17, which was rejected by STMX's independent directors. SyStemix Inc....
BioCentury | Mar 23, 2009
Finance

Ebb & Flow

...University and has helped form three stem cell companies: Cellerant Therapeutics , StemCells (NASDAQ:STEM) and Systemix...
BioCentury | Dec 4, 2006
Strategy

PER.C6 perseverance

...thinking beyond that," Valerio said. "In those days the leading gene therapy companies were Somatix, SyStemix...
BioCentury | Jun 2, 2003
Finance

Ebb & Flow

...period, 384 stocks have advanced. The BioCentury 100 has risen 39% since March 7. Rebirth Systemix...
...stem cell space, had a resurrection of sorts last week. Cellerant, which is based around Systemix...
...announced it exclusively licensed the IP rights from Stanford and Novartis (SWX:NOVN; NVS), which acquired Systemix...
BioCentury | May 29, 2003
Financial News

Cellerant raises $10 million

...was formed around the same IP that once was a part of another Weissman company, SyStemix...
BioCentury | Sep 4, 2001
Finance

Ebb & Flow

...of fetal tissue in research has recently been the subject of active political debate." - SyStemix's...
...the currently breathless media hoo hah, the controversy over stem cells is old hat. Recall SyStemix...
...marrow transplantation. And, like many of the companies that sold IPOs in the early 90s, SyStemix...
BioCentury | Jan 2, 2001
Company News

Axys management update

...Autoimmune/Inflammation Hired: Daniel Makover as VP of business development, formerly director of business development for SyStemix Inc. WIR...
BioCentury | Jul 17, 2000
Company News

Valentis management update

...as VP of medical and regulatory affairs, formerly executive director of clinical R&D at the Systemix/GTI...
BioCentury | Feb 7, 2000
Company News

CytoTherapeutics management update

...StemCells Inc. subsidiary Hired: Iris Brest as general counsel, formerly VP and general counsel for SyStemix Inc. WIR...
BioCentury | Jan 17, 2000
Company News

Targeted Genetics, Novartis deal

...Novartis subsidiaries Genetic Therapy Inc. (Gaithersburg, Md.) and SyStemix Inc. (Palo Alto, Calif.) received a non-exclusive, worldwide...
Items per page:
1 - 10 of 53